Showing promise in the arena of weight management therapy, retatrutide presents a unique method. Unlike many existing medications, retatrutide operates as a twin agonist, concurrently affecting both GLP peptide-1 (GLP-1) and glucose-sensitive insulinotropic polypeptide (GIP) receptors. The simultaneous activation promotes multiple advantageous effe… Read More